Community reports on retatrutide, summarised responsibly

Thousands of people in the UK are using products sold as retatrutide and talking about it online. This section summarises what they describe, as themes rather than stories, and sets each theme against what the trials actually found. It starts with a caveat that applies to every word of it.

What this section is

People who use these products describe their experiences in public: on forums, in comment sections, in videos and in group chats. Read enough of them and patterns emerge. Some match the trial data closely. Some do not appear in the trials at all. Some are the opposite of what the trials would predict.

Those patterns are worth recording, for two reasons. First, they are what a person deciding whether to use one of these products will actually hear, and it helps to know how the reports compare with the evidence. Second, the reports that do not match the trials are where the real-world risks show up: the liver injuries in Australia were noticed by doctors, not by a trial.^[3]

What this section is not

• It is not a review site. There are no ratings, no "it worked for me", no photos.
• It is not a guide. There is no dosing detail, no schedule, no "what people typically do". Where a community report involves that kind of detail, we leave it out entirely.
• It is not evidence. A thousand people reporting the same thing about an unverified product is a thousand anecdotes about a thousand different vials.
• It does not link to forums. We describe themes; we do not send you to the threads.

The fundamental caveat

Everything on the side-effects pages comes from trials in which every participant received the same pharmaceutical-grade product at a known strength. Nothing in a community report does.

Laboratory testing of products sold as retatrutide in 2026 found strengths around 30% above the label in some, 30% below in others, one with none of the drug, and one that had roughly double the labelled amount at 16.6% purity.^[1][4] The peptide was typically about a tenth of what was in the vial; the rest was unaccounted for.^[1]

So when someone reports nausea, or nothing, or a rash, or feeling terrible, we do not know what they took. That is not a technicality. It is the reason a community report cannot tell you what retatrutide does, only what happened to someone who used a product with that name on it. What is actually in the vials has the full testing picture.

In this section

1. 1.What people report after using products sold as retatrutide

   The common themes in community reports about products sold as retatrutide, how often each comes up, what the trials found, and what a clinician would say.

2. 2.Retatrutide misinformation tracker: claims vs evidence

   Thirteen common claims about retatrutide from social media and group chats, each checked against the trials, regulators and lab tests, with a verdict.